Selinexor Treatment of Advanced Relapsed/Refractory Squamous Cell Carcinomas
Clinical trial NCT02213133 · TERMINATED
Trial details
- NCT number
- NCT02213133
- Sponsor
- Karyopharm Therapeutics Inc
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-09-22
- Primary completion
- 2015-12-10
- Enrollment
- 45
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.